Evaluation of a national multidisciplinary meeting for non-tuberculous mycobacterial disease.
作者信息
Lemson A, Koster T A, Carpaij N, Magis-Escurra C, Boeree M, Stemkens R, Aarnoutse R E, van Laarhoven A, van Crevel R, van Ingen J, Hoefsloot W
机构信息
Department of Pulmonary Diseases, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands.
Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands.
出版信息
IJTLD Open. 2024 Jun 1;1(6):279-281. doi: 10.5588/ijtldopen.24.0044. eCollection 2024 Jun.
Abstract
摘要
相似文献
1
Evaluation of a national multidisciplinary meeting for non-tuberculous mycobacterial disease.非结核分枝杆菌病全国多学科会议评估
IJTLD Open. 2024 Jun 1;1(6):279-281. doi: 10.5588/ijtldopen.24.0044. eCollection 2024 Jun.
2
Sudapyridine (WX-081) antibacterial activity against , , and and .舒巴吡啶（WX-081）对 、 、 和 的抗菌活性。
mSphere. 2024 Feb 28;9(2):e0051823. doi: 10.1128/msphere.00518-23. Epub 2024 Jan 19.
3
Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report.分枝杆菌脓肿分枝杆菌继发显微镜下多血管炎支气管扩张症 1 例报告
BMC Pulm Med. 2018 Nov 19;18(1):170. doi: 10.1186/s12890-018-0732-3.
4
Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.非结核分枝杆菌肺病由鸟分枝杆菌复合群和脓肿分枝杆菌复合群混合感染引起。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01105-18. Print 2018 Oct.
5
A prospective study of non-tuberculous mycobacterial disease among tuberculosis suspects at a tertiary care centre in north India.印度北部一家三级护理中心的结核疑似患者中非结核分枝杆菌病的前瞻性研究。
Indian J Med Res. 2019 Nov;150(5):458-467. doi: 10.4103/ijmr.IJMR_194_19.
6
Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing.非结核分枝杆菌肺病患者的临床特征：一项在北京某三甲医院进行的为期七年的随访研究。
Front Cell Infect Microbiol. 2023 Jun 22;13:1205225. doi: 10.3389/fcimb.2023.1205225. eCollection 2023.
7
Clinical aspects of the Mycobacterium abscessus complexAuthors' replyClinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian AmazonBurden of non-tuberculous mycobacterial pulmonary disease in GermanyBritish Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).脓肿分枝杆菌复合体的临床方面 作者回复 巴西亚马逊地区脓肿分枝杆菌复合体分枝杆菌引起的肺部感染患者的临床方面 德国非结核分枝杆菌肺病负担 英国胸科学会非结核分枝杆菌肺病（NTM-PD）管理指南
J Bras Pneumol. 2018 Sep-Oct;44(5):434-435. doi: 10.1590/S1806-37562018000000193.
8
Failure among Patients with Non-Tuberculous Mycobacterial Infections in Skin, Soft Tissue, and Musculoskeletal System in Southern Taiwan, 2012-2015.2012-2015 年台湾南部皮肤、软组织和肌肉骨骼系统中非结核分枝杆菌感染患者的失败情况。
Surg Infect (Larchmt). 2019 Sep;20(6):492-498. doi: 10.1089/sur.2018.314. Epub 2019 May 8.
9
A Case Series of Non-Tuberculous Mycobacterial Pulmonary Disease Masquerading as Malignancy From a Community-Based Hospital.来自一家社区医院的伪装成恶性肿瘤的非结核分枝杆菌肺病病例系列
J Med Cases. 2023 Apr;14(4):141-147. doi: 10.14740/jmc4098. Epub 2023 Apr 30.
10
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.日本一家转诊医院中，非结核分枝杆菌肺病和结核病的流行病学和临床特征的相互关系变化。
Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.
引用本文的文献
1
Management challenges and outcomes for non-tuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的管理挑战与结局
IJTLD Open. 2024 Jul 1;1(7):332-334. doi: 10.5588/ijtldopen.24.0140. eCollection 2024 Jul.
本文引用的文献
1
Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?鸟分枝杆菌复合群肺病的治疗：何时开始治疗及选择何种治疗方案？
Clin Chest Med. 2023 Dec;44(4):771-783. doi: 10.1016/j.ccm.2023.06.009. Epub 2023 Aug 14.
2
Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis.非结核分枝杆菌性肺病的危险因素：系统文献回顾和荟萃分析。
Chest. 2023 Nov;164(5):1115-1124. doi: 10.1016/j.chest.2023.06.014. Epub 2023 Jun 17.
3
Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data.基于药物配给数据的荷兰非结核分枝杆菌肺病患者的真实世界治疗模式。
BMC Pulm Med. 2023 Jun 20;23(1):218. doi: 10.1186/s12890-023-02460-1.
4
Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease.鸟分枝杆菌复合群肺病中分枝杆菌生长指示管阳性时间可作为治疗反应的早期生物标志物。
Chest. 2022 Feb;161(2):370-372. doi: 10.1016/j.chest.2021.08.046. Epub 2021 Aug 13.
5
The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands.荷兰非结核分枝杆菌肺病的流行病学
ERJ Open Res. 2021 Jul 12;7(3). doi: 10.1183/23120541.00207-2021. eCollection 2021 Jul.
6
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey.抗酸分枝杆菌肺病的药物毒性管理：专家小组调查。
Clin Infect Dis. 2021 Jul 1;73(1):e256-e259. doi: 10.1093/cid/ciaa1361.
7
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.非结核分枝杆菌肺病的治疗：美国胸科学会/欧洲呼吸学会/欧洲临床微生物学与感染病学会/美国感染病学会官方临床实践指南
Eur Respir J. 2020 Jul 7;56(1). doi: 10.1183/13993003.00535-2020. Print 2020 Jul.
8
Non-tuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病。
Eur Respir J. 2019 Jul 11;54(1). doi: 10.1183/13993003.00250-2019. Print 2019 Jul.
9
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease.吸入高渗盐水作为非结核分枝杆菌肺病治疗方式的疗效
Eur Respir J. 2019 Jul 11;54(1). doi: 10.1183/13993003.02143-2018. Print 2019 Jul.
10
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.非结核分枝杆菌肺病患者对管理指南的依从性较差。
Eur Respir J. 2017 Feb 15;49(2). doi: 10.1183/13993003.01855-2016. Print 2017 Feb.
Zotero 插件